Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Equities
A268600
KR7268600004
Biotechnology & Medical Research
More news
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 57 | 2014-08-27 |
Sun-Hong Kwon
PRN | Corporate Officer/Principal | 51 | 2021-03-28 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 61 | 2019-03-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 57 | 2014-08-27 |
Sun-Hong Kwon
BRD | Director/Board Member | 51 | 2021-03-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 405K | |
| +0.06% | -5.67% | +19.64% | +98.30% | 52.08B | |
| -0.05% | +0.19% | +174.91% | +911.92% | 42B | |
| -3.02% | -0.37% | +61.43% | +16.56% | 38.48B | |
| -1.05% | -3.57% | -22.07% | -48.47% | 22.56B | |
| +0.20% | +0.50% | +40.03% | -33.84% | 19.52B | |
| -1.17% | -4.47% | +85.53% | -37.50% | 17.21B | |
| +0.60% | -2.09% | +89.31% | +180.34% | 13.75B | |
| -1.08% | -6.68% | -2.52% | +385.47% | 13.4B | |
| +0.45% | -5.20% | +125.42% | - | 12.06B | |
| Average | -3.39% | -4.29% | +63.52% | +184.10% | 25.67B | |
| Weighted average by Cap. | -0.50% | -3.79% | +65.77% | +225.13% |
Employees
4
Calendar
